Skip to main content
SpringerLink
Log in

Ovarian Cancer

  • Chapter
  • First Online:
Handbook of Evidence-Based Radiation Oncology

  • 2661 Accesses

Abstract

This chapter will discuss the epidemiology, workup, staging, treatment recommendations, key studies, and radiation treatment techniques for ovarian cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Alektiar KM, Chi DS, Kauff ND, Fuks ZY. Cancer of the ovary. In: Leibel SA, Phillips TL, editors. Textbook of radiation oncology. 3rd ed. Philadelphia: Saunders; 2010. p. 1052–66.

    Chapter  Google Scholar 

  • Armstrong DK, Bundy B, Wenzel L, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med.2006;354:34–43.

    Article  CAS  Google Scholar 

  • Bell J, Brady MF, Young RC, et al. Randomized phase III trial of three versus six cycle of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a gynecologic oncology group study. Gyn Oncol. 2006;102:432–9.

    Article  CAS  Google Scholar 

  • Bundy B, Alberts DS, et al. Phase III trial of standard-dose intravenous Cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and Intraperitoneal Cisplatin in Small-Volume Stage III Ovarian Carcinoma: An Intergroup Study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Group. J Clin Oncol. 2001;19:1001–7.

    Article  Google Scholar 

  • Burger RA, Brady MF, Bookman MA, et al. Incorporation of bevacizumab in the primary treatment of ovarian cancer. N Engl J Med. 2011;365(26):2473–83.

    Article  CAS  Google Scholar 

  • Chan JK, Brady MF, Penson RT, et al. Weekly vs. every-3-week paclitaxel and carboplatin for ovarian cancer. N Engl J Med. 2016;374(8):738–48.

    Article  CAS  Google Scholar 

  • Chiara S, Conte P, Franzone P, et al. High-risk early-stage ovarian cancer. Randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy. Am J Clin Oncol. 1994;17(1):72–6.

    Article  CAS  Google Scholar 

  • Dembo AJ. Abdominopelvic radiotherapy in ovarian cancer. A 10-year experience. Cancer. 1985;55(9 Suppl):2285–90.

    Article  CAS  Google Scholar 

  • Edge SB, American Joint Committee on Cancer. American Cancer Society. AJCC cancer staging manual. 7th ed. New York: Springer Science+Business Media; 2010.

    Google Scholar 

  • Ferriss JS, Java JJ, Bookman MA, et al. Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: an NRG oncology/GOG study. Gynecol Oncol. 2015;139(1):17–22.

    Article  CAS  Google Scholar 

  • Fyles AW, Dembo AJ, Bush RS, et al. Analysis of complications in patients treated with abdomino-pelvic radiation therapy for ovarian carcinoma. Int J Radiat Oncol Biol Phys. 1992;22(5):847–51.

    Article  CAS  Google Scholar 

  • Hoskins PJ, Le N, Gilks B, et al. Low-stage ovarian clear cell carcinoma: population-based outcomes in British Columbia, Canada, with evidence for a survival benefit as a result of irradiation. J Clin Oncol. 2012;30(14):1656–62.

    Article  CAS  Google Scholar 

  • ICON and EORTC-ACTION investigators. International collaboration on ovarian neoplasm trial 1 and adjuvant chemotherapy in ovarian neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early stage ovarian cancer. J Natl Cancer Inst. 2003;95:105–12.

    Article  Google Scholar 

  • Katsumata N, Yasuda M, Isonishi S, et al. Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial. Lancet Oncol. 2013;14(10):1020–6.

    Article  CAS  Google Scholar 

  • Kojs Z, Glinski B, Reinfuss M, et al. Results of a randomized prospective trial comparing postoperative abdominopelvic radiotherapy with postoperative chemotherapy in early ovarian cancer. Cancer Radiother. 2001;5:5–11.

    Google Scholar 

  • Lambert HE, Rustin GJ, Gregory WM, Nelstrop AE. A randomized trial comparing single-agent carboplatin with carboplatin followed by radiotherapy for advanced ovarian cancer: a North Thames Ovary Group study. J Clin Oncol. 1993;11(3):440–8.

    Article  CAS  Google Scholar 

  • Lee L, Berkowitz R, Matulonis U. Ovarian and fallopian tube cancer. In: Halperin CE, Wazer DE, Perez CA, Brady LW, editors. Principles and practice of radiation oncology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013. p. 1446–64.

    Google Scholar 

  • McGuire WP, Hosking WJ, Brady MF, et al. Taxol and cisplatin improves outcome in patients with advanced ovarian cancer as compared to cytoxan/cisplatin. N Engl J Med. 1996;334(1):1–6.

    Article  CAS  Google Scholar 

  • National Cancer Institute Surveillance, Epidemiology, and End Results Program (SEER). 2016. http://seer.cancer.gov/statfacts/html/ovary.html. Accessed 20 Aug 2016.

  • National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Ovarian Cancer (Version 1.2016). 2016. Available at: https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf. Accessed on 21 Aug 2016.

  • Oza AM, Cook AD, Pfisterer J, et al. Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. Lancet Oncol. 2015;16(8):928–36.

    Article  CAS  Google Scholar 

  • Ozols RF, Bundy BN, Greer E, et al. Phase III trials of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecology Oncology Group study. J Clin Oncol. 2003;21:3194–200.

    Article  CAS  Google Scholar 

  • Perren TJ, Swart AM, Pfisterer J, et al. A phase 3 trial of bevacizumab in ovarian cancer. N Engl J Med. 2011;365(26):2484–96.

    Article  CAS  Google Scholar 

  • Piccart M, Bertelsen K, James K, et al. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst. 2000;92:699–708.

    Article  CAS  Google Scholar 

  • Rochet N, Kieser M, Sterzing F, et al. Phase II study evaluating consolidation whole abdominal intensity-modulated radiotherapy (IMRT) in patients with advanced ovarian cancer stage FIGO III--the OVAR-IMRT-02 Study. BMC Cancer. 2011;11:41.

    Google Scholar 

  • Rochet N, Lindel K, Katayama S, et al. Intensity-modulated whole abdomen irradiation following adjuvant carboplatin/taxane chemotherapy for FIGO stage III ovarian cancer: four-year outcomes. Strahlenther Onkol. 2015;191:582-9.

    Article  Google Scholar 

  • Sorbe B. Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: a randomized, controlled, clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatment. Int J Gynecol Cancer. 2003;13(3):278–86.

    Article  CAS  Google Scholar 

  • Swenerton KD, Santos JL, Gilks CB, et al. Histotype predicts the curative potential of radiotherapy: the example of ovarian cancers. Ann Oncol. 2011;22:341–7.

    Article  Google Scholar 

  • Vicus D, Small W Jr, Covens A. Ovarian cancer. In: Gunderson LL, Tepper JE, editors. Clinical radiation oncology. 4th ed. Philadelphia: Churchill Livingstone; 2015. p. 1264–1283.e5.

    Google Scholar 

Download references

Acknowledgment

We thank R. Scott Bermudez MD, James Rembert MD for their work on the prior edition of this chapter.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA

    Serah Choi & I-Chow J. Hsu

Authors
  1. Serah Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I-Chow J. Hsu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I-Chow J. Hsu .

Editor information

Editors and Affiliations

  1. The Oregon Clinic, Providence St. Vincent Medical Center, Portland, OR, USA

    Eric K. Hansen

  2. Department of Radiation Oncology, University of California, San Franc, SAN FRANCISCO, CA, USA

    Mack Roach III

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Choi, S., Hsu, IC.J. (2018). Ovarian Cancer. In: Hansen, E., Roach III, M. (eds) Handbook of Evidence-Based Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-62642-0_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-62642-0_31

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-62641-3

  • Online ISBN: 978-3-319-62642-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation